Literature DB >> 2570900

Smoking as a risk factor for cerebral ischaemia.

G A Donnan1, J J McNeil, M A Adena, A E Doyle, H M O'Malley, G C Neill.   

Abstract

To assess whether a rigorous clinical classification, based on computerised tomography, of patients with cerebral ischaemia would identify subgroups at higher or lower risk with respect to cigarette smoking habits, a case-control study was carried out on 422 cases of first-episode cerebral ischaemia matched for age and sex with 422 community-based neighbourhood controls. Patients with ischaemic stroke due to extracranial or intracranial vascular disease were at higher risk from smoking than has previously been reported for stroke (relative risk 5.7, 95% confidence interval 2.8, 12.0) whereas those with stroke due to cardiac emboli had no excess risk associated with smoking (relative risk 0.4 [0.1, 1.8]). After cessation of smoking, the relative risk declined gradually over 10 years, at the end of which time a significant risk was still evident. This finding may imply that the risk incurred by smoking is due mainly to atheroma formation, rather than transient haematological effects. Exposure to smoking by a spouse was an independent risk factor for the whole group of cerebral ischaemia patients (relative risk 1.7 [1.1, 2.6]), but this was not so for smoking by either parent (relative risk 1.2 [0.8, 1.8]). These findings suggest that smoking is a more potent risk factor for the most common form of ischaemic stroke than has previously been appreciated. The persistent nature of the risk even after cessation of smoking and the possible risk associated with passive exposure strengthens public health arguments against smoking.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2570900     DOI: 10.1016/s0140-6736(89)90894-5

Source DB:  PubMed          Journal:  Lancet        ISSN: 0140-6736            Impact factor:   79.321


  30 in total

1.  Transient ischaemic attacks: which patients are at high (and low) risk of serious vascular events?

Authors:  G J Hankey; J M Slattery; C P Warlow
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-08       Impact factor: 10.154

2.  Different risk factor profiles between subtypes of ischemic stroke. A case-control study in Korean men.

Authors:  Yun-Mi Song; Sun Uck Kwon; Joohon Sung; Shah Ebrahim; George Davey Smith; Sung Sunwoo; Yeong Sook Yun
Journal:  Eur J Epidemiol       Date:  2005       Impact factor: 8.082

Review 3.  The impact of neuropsychological deficits on functional stroke outcomes.

Authors:  Suzanne Barker-Collo; Valery Feigin
Journal:  Neuropsychol Rev       Date:  2006-08-09       Impact factor: 7.444

4.  Overweight and stroke in the Whitehall study.

Authors:  R Shinton; M Shipley; G Rose
Journal:  J Epidemiol Community Health       Date:  1991-06       Impact factor: 3.710

5.  Prediction of stroke in the general population in Europe (EUROSTROKE): Is there a role for fibrinogen and electrocardiography?

Authors:  K G M Moons; M L Bots; J T Salonen; P C Elwood; A Freire de Concalves; Y Nikitin; J Sivenius; D Inzitari; V Benetou; J Tuomilehto; P J Koudstaal; D E Grobbee
Journal:  J Epidemiol Community Health       Date:  2002-02       Impact factor: 3.710

6.  Smoking and stroke: a causative role. Heavy smokers with hypertension benefit most from stopping.

Authors:  M I Aldoori; S H Rahman
Journal:  BMJ       Date:  1998-10-10

7.  Smoking habits and risk of fatal stroke: 18 years follow up of the Oslo Study.

Authors:  L L Håheim; I Holme; I Hjermann; P Leren
Journal:  J Epidemiol Community Health       Date:  1996-12       Impact factor: 3.710

8.  Estimate of deaths attributable to passive smoking among UK adults: database analysis.

Authors:  Konrad Jamrozik
Journal:  BMJ       Date:  2005-03-01

Review 9.  The benefits of stopping smoking and the role of nicotine replacement therapy in older patients.

Authors:  S G Gourlay; N L Benowitz
Journal:  Drugs Aging       Date:  1996-07       Impact factor: 3.923

10.  Smoking as a crucial independent determinant of stroke.

Authors:  Seana L Paul; Amanda G Thrift; Geoffrey A Donnan
Journal:  Tob Induc Dis       Date:  2004-06-15       Impact factor: 2.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.